Division of Vascular and Endovascular Surgery, Department of Surgery, Stanford University School of Medicine, Palo Alto, CA; Veterans Affairs Healthcare System, Surgical Service Line, Section of Vascular Surgery, Palo Alto, CA.
University Hospital Harrington Heart & Vascular Institute, Case Western Reserve University School of Medicine, Cleveland, OH.
Ann Vasc Surg. 2023 Nov;97:74-81. doi: 10.1016/j.avsg.2023.05.008. Epub 2023 May 27.
Practice guidelines recommend elective repair for abdominal aortic aneurysms (AAAs) ≥ 5.5 cm in men and ≥ 5 cm in women to prevent rupture; however, some rupture at smaller diameters. We identify risk factors for rupture AAA (rAAA) below this threshold and compare outcomes following rAAA repair above/below size criteria.
The Vascular Quality Initiative (2013-2019) was queried for patients undergoing repair for rAAA and stratified based on diameter into small and large cohorts [Small: < 5.5 cm (men), < 5.0 cm (women)]. Univariate analysis was performed, and Kaplan-Meier analysis compared overall survival, aneurysm-related mortality, and reintervention at 12 months.
Five thousand one hundred sixty two rAAA were identified. Small rAAA patients [n = 588] were more likely to have hypertension (81.3% vs. 77.0%, P < 0.02), diabetes (18.2% vs. 14.9%, P < 0.04), and end-stage renal disease (2.9% vs. 0.9%, P < 0.01) and be on optimal medical therapy (32.1% vs. 26.8%, P < 0.01). Women were more likely to rupture at smaller diameters compared to men (P < 0.01). Small rAAA patients were more likely to undergo endovascular aortic repair (EVAR) (70.2% vs. 56.0%, P < 0.01) and had lower in-hospital mortality (17.7% vs. 27.7%, P < 0.01) and fewer perioperative complications across all categories. At 12 months, small rAAA patients had better overall survival, freedom from aneurysm-related mortality, and freedom from reintervention, largely driven by EVAR approach.
More than 11% of patients presenting with ruptured AAA were below the recommended size threshold for repair, and they tended to be younger, non-White, and have hypertension, diabetes, and/or renal failure. Patients with small rAAA experienced lower in-hospital morbidity and mortality and improved 1-year survival, and EVAR was associated with better outcomes than open repair. However, women more frequently rupture at smaller diameters compared to men. Given contemporary elective outcomes for women, a randomized controlled trial for EVAR versus surveillance at a sex-specific size threshold is needed.
临床指南建议对直径≥5.5 厘米的男性和≥5 厘米的女性的腹主动脉瘤(AAA)进行择期修复,以预防破裂;然而,有些瘤体在更小的直径时就会破裂。我们确定了这个阈值以下破裂 AAA(rAAA)的危险因素,并比较了大小标准以上/以下的 rAAA 修复后的结果。
在血管质量倡议(2013-2019 年)中查询接受 rAAA 修复的患者,并根据直径分为小直径和大直径队列[小直径:男性<5.5 厘米,女性<5.0 厘米]。进行单变量分析,并进行 Kaplan-Meier 分析,比较 12 个月时的总体生存率、与动脉瘤相关的死亡率和再干预。
确定了 5162 例 rAAA。小 rAAA 患者[n=588]更可能患有高血压(81.3%比 77.0%,P<0.02)、糖尿病(18.2%比 14.9%,P<0.04)和终末期肾病(2.9%比 0.9%,P<0.01),并接受最佳药物治疗(32.1%比 26.8%,P<0.01)。与男性相比,女性更有可能在较小的直径处破裂(P<0.01)。小 rAAA 患者更有可能接受血管内主动脉修复(EVAR)(70.2%比 56.0%,P<0.01),住院死亡率较低(17.7%比 27.7%,P<0.01),所有类别中围手术期并发症较少。在 12 个月时,小 rAAA 患者的总体生存率、免于动脉瘤相关死亡率和免于再干预的生存率更好,这主要归因于 EVAR 方法。
超过 11%的破裂 AAA 患者的直径低于推荐的修复阈值,他们往往更年轻、非白人,患有高血压、糖尿病和/或肾衰竭。小 rAAA 患者的住院发病率和死亡率较低,1 年生存率提高,EVAR 与开放修复相比,结果更好。然而,与男性相比,女性更常在较小的直径处破裂。鉴于女性的现代择期治疗结果,需要进行一项针对女性特定大小阈值的 EVAR 与监测的随机对照试验。